TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.

TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.

Item
http://www.wikidata.org/entity/Q33803841
Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancerUncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoMAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasComputational Reconstruction of NFκB Pathway Interaction Mechanisms during Prostate Cancer.Aberrant expression of COT is related to recurrence of papillary thyroid cancer.AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.Inducible Mouse Models for Cancer Drug Target Validation.Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients.Tpl2 induces castration resistant prostate cancer progression and metastasis.Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.TPL2 is a key regulator of intestinal inflammation in C. difficile infection.
P2860

TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.

Item
http://www.wikidata.org/entity/Q33803841
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@ast
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@en
type
label
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@ast
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@en
prefLabel
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@ast
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
TPL2/COT/MAP3K8 (TPL2) activat ...... (ADI) prostate cancer growth.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0016205
P407
P433
P478
P50
P577
P5875
P698
P932